India Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

India Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The India Clinical Nutrition for Diabetes Care Market was valued at $39.10 Mn in 2023 and is predicted to grow at a CAGR of 7.78% from 2023 to 2030, to $66.06 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Amway India, Pfizer Inc., and Zoic Pharmaceuticals among others.

ID: IN10INPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Avantika Gupta

Buy Now

India Clinical Nutrition for Diabetes Care Market Executive Summary

The India Clinical Nutrition for Diabetes Care Market is at around $39.10 Mn in 2023 and is projected to reach $66.06 Mn in 2030, exhibiting a CAGR of 7.78% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Abbott Nutrition, Himalaya Wellness Company is known for its extensive portfolio of medications, including those essential for diabetes care. Amway India, Dabur India, and Ambit Bio-Medix are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

India Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: Diabetes has increased worldwide in recent decades due to factors such as sedentary lifestyles, poor eating habits, and increasing obesity. According to a report published in The Lancet Diabetes and Endocrinology, this shows that 11.4 percent or 101 Mn Indians have diabetes. It is more common in urban areas than in rural India. There is increasing recognition of the value of nutritional therapy in the management of diabetes and the importance of clinical nutrition products and services to improve patient outcomes.

Rising demand for personalized dietary plans and solutions: Diabetic patients are increasingly looking for customized diets and special nutritional products to help regulate blood sugar, manage weight, and prevent complications. The trend of individual nutrition is based on individual needs, preferences, and health status. Many consumers are willing to pay more for products perceived as healthier, indicating a strong desire to make informed decisions about their eating habits.

Advancements in nutritional science and product development: As the healthcare industry grows, so does research and development in clinical nutrition. Healthcare providers and those involved in managing diabetes are gaining a better understanding and identifying specific dietary patterns, nutrients, and supplements that can reduce insulin resistance and diabetes-related complications, and further improve glycemic control. These insights are also expected to contribute to the market growth in the coming years.

Initiatives for diabetes management: Companies like Baxter International Inc., a global leader in clinical nutrition, have led initiatives to raise awareness about proper nutrition for diabetes management in India.

Market Restraints

High Cost of Specialized Products: Specialized clinical nutrition products designed for diabetes management come at a higher price point compared to regular dietary supplements or traditional food options. This increased cost can create barriers to access for individuals, especially those belonging to low-income households or residing in areas with limited healthcare services. The financial strain associated with the elevated prices of specialized therapeutic nutrition items underscores the challenges faced in diabetic care.

Competition from Traditional Dietary Practices: India has a rich cultural heritage of traditional dietary practices and home remedies for managing health conditions like diabetes. The preference for these traditional approaches may sometimes overshadow the adoption of modern clinical nutrition solutions, restraining market growth.

Lack of Access to Registered Dietitians: The availability of registered dietitians, especially in rural or underserved areas of India, is limited. This lack of access to qualified nutrition professionals who can provide personalized assessments and counseling for diabetic patients is a major restraint for market growth.

Regulatory Challenges
The regulatory landscape for clinical nutrition products and services in India may pose some challenges in terms of product approvals, labeling requirements, and reimbursement policies. These regulatory hurdles can slow down the market expansion.

Regulatory Landscape and Reimbursement Scenario

In India, clinical nutrition products for diabetes management fall under the purview of the Food Safety and Standards Authority of India (FSSAI), which regulates the manufacture, storage, distribution, sale, and import of food products, including specialized nutrition items. The FSSAI has specific regulations for foods for special medical purposes (FSMP), which include formulations intended for the dietary management of diseases, disorders, or medical conditions of individuals. These regulations cover aspects like labeling, composition, and safety requirements for FSMP products.

India currently lacks a widespread reimbursement scheme specifically for clinical nutrition services related to diabetes care. Some private health insurance plans may offer limited coverage for consultations with dietitians or nutritionists. However, the extent of coverage and specific conditions covered can vary greatly between insurance providers.

Competitive Landscape

Key Players

Here are some of the major key players in the India Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Pfizer Inc.
Ambit Bio Medix
Nestlé Health Science
Zoic Pharmaceuticals
Bayer India
Uniray Lifesciences
Himalaya Wellness Company
Amway India
Dabur India Limited

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

India Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.